ARTICLE | Company News
Array, Genentech in cancer deal
August 9, 2011 12:09 AM UTC
Array BioPharma Inc. (NASDAQ:ARRY) partnered with Genentech Inc. to develop each company's oral checkpoint kinase 1 (Chk1) inhibitor for cancer. Genentech will be responsible for all clinical developm...